Yahoo Finance7d
Allurion Stock Skyrockets 80% After Hours Following Clinical Study Announcement
Along with a Virtual Care Suite that provide tools for healthcare professionals to monitor and modify treatments, the Allurion Program has a swallowable gastric balloon that calls for no surgical ...
Allurion Announces Issuance Of New U.S. Patent For Next-Gen Obesity Weight Loss Device
Allurion Technologies, Inc. (ALUR) a Massachusetts-based medical device company Tuesday announced the issuance of a new U.S. patent ...
Allurion Stock Triples on Plan to Test Gastric Balloon With Obesity Drugs
Allurion Technologies shares soared 200% Friday as it planned to test its gastric balloon with the key ingredient in popular weight-loss drugs to see if the combination improves patients' muscle mass.
Yahoo Finance7d
Allurion Announces Plans To Optimize Muscle Mass During GLP-1 Therapy In Combination With the Allurion Program
NATICK, Mass., January 23, 2025--(BUSINESS WIRE)--Allurion Technologies, Inc. ("Allurion" or the "Company") (NYSE: ALUR), a company dedicated to ending obesity, today ...
Joplin Globe7d
Allurion to Raise Approximately $7.4 Million of Gross Proceeds in Offering Priced At-the-Market
Allurion Technologies, Inc. (“Allurion” or the “Company”) (NYSE: ALUR), a company dedicated to ending obesity, today announced that it has entered into a definitive securities purchase agreement with ...
Nasdaq10d
Allurion Announces Notification of Issuance of New U.S. Patent on Next-Generation Weight Loss Device for the Treatment of Obesity
NATICK, Mass.--(BUSINESS WIRE)-- Allurion Technologies, Inc. (“Allurion” or the “Company”) (NYSE: ALUR), a company dedicated to ending obesity, today ...